Marco Lenzi

17.8k total citations · 5 hit papers
153 papers, 12.3k citations indexed

About

Marco Lenzi is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Marco Lenzi has authored 153 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Hepatology, 97 papers in Epidemiology and 25 papers in Rheumatology. Recurrent topics in Marco Lenzi's work include Liver Disease Diagnosis and Treatment (89 papers), Liver Diseases and Immunity (84 papers) and Hepatitis C virus research (56 papers). Marco Lenzi is often cited by papers focused on Liver Disease Diagnosis and Treatment (89 papers), Liver Diseases and Immunity (84 papers) and Hepatitis C virus research (56 papers). Marco Lenzi collaborates with scholars based in Italy, United Kingdom and United States. Marco Lenzi's co-authors include Giulio Marchesini, Stefania Natale, Elisabetta Bugianesi, Nazario Melchionda, Gabriele Forlani, Luigi Muratori, Francesco B. Bianchi, F. Cassani, Giampaolo Bianchi and Mara Brizi and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Marco Lenzi

147 papers receiving 12.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NAFLD fibrosis score

2007 2.3k citations Giulio Marchesini, Marco Lenzi et al. Hepatology profile →
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome

2003 2.1k citations Giulio Marchesini, Elisabetta Bugianesi et al. Hepatology profile →
Nonalcoholic Fatty Liver Disease

2001 2.1k citations Giulio Marchesini, Giampaolo Bianchi et al. profile →
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

2016 653 citations Fabio Conti, F. Buonfiglioli et al. profile →
Diagnosis and management of autoimmune hepatitis

2023 112 citations Luigi Muratori, Ansgar W. Lohse et al. BMJ profile →

Peers

Countries citing papers authored by Marco Lenzi

Since Specialization

Citations

This map shows the geographic impact of Marco Lenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Lenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Lenzi more than expected).

Fields of papers citing papers by Marco Lenzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Lenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Lenzi. The network helps show where Marco Lenzi may publish in the future.

Co-authorship network of co-authors of Marco Lenzi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Lenzi. A scholar is included among the top collaborators of Marco Lenzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Lenzi. Marco Lenzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Easy recognition and high autoimmune hepatitis specificity of smooth muscle antibodies giving an actin microfilament immunofluorescent pattern on embryonal vascular smooth muscle cells 2024 ·Clinical & Experimental Immunology ·Alessandro Granito, Paolo Muratori, Γεώργιος Παππάς, Marco Lenzi, Albert J. Czaja, Luigi Muratori	1
2	Diagnosis and management of autoimmune hepatitis breakdown → 2023 ·BMJ ·Luigi Muratori, Ansgar W. Lohse, Marco Lenzi	112
3	Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence 2022 ·Journal of Clinical and Translational Hepatology ·(unknown), Claudine Lalanne, Chiara Quarneti, (unknown), Chiara Ricci, Alessandro Granito, Luigi Muratori, Marco Lenzi	7
4	Decompensated Cirrhosis as Presentation of LKM1/LC1 Positive Type 2 Autoimmune Hepatitis in Adulthood. A Rare Clinical Entity of Difficult Management 2021 ·SHILAP Revista de lepidopterología ·Alessandro Granito, (unknown), Chiara Ricci, (unknown), Luigi Muratori, Francesco Vasuri, (unknown), Marco Lenzi, Paolo Muratori	4
5	Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis with acute onset 2021 ·Liver International ·Paolo Muratori, Alessandro Granito, Marco Lenzi, Luigi Muratori	12
6	On the Necessity of a Customized Knee Spacer in Peri-Prosthetic Joint Infection Treatment: 3D Numerical Simulation Results 2021 ·Journal of Personalized Medicine ·Marco Balato, Carlo Petrarca, (unknown), Marco Lenzi, (unknown), Andrea Sellitto, (unknown), Mauro Zarrelli, Giovanni Balato	4
7	Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 2018 ·Digestive and Liver Disease ·Andrea Casadei‐Gardini, Francesco Giuseppe Foschi, Fabio Conti, Elisabetta Petracci, Ranka Vukotic, Giorgia Marisi, F. Buonfiglioli, Giovanni Vitale, Federico Ravaioli, Stefano Gitto, Gabriella Verucchi, Marco Lenzi, Luigi Bolondi, G. Mazzella, S. Brillanti, Pietro Andreoné	47
8	The Serological Profile of the Autoimmune Hepatitis/Primary Biliary Cirrhosis Overlap Syndrome 2009 ·The American Journal of Gastroenterology ·Paolo Muratori, Alessandro Granito, Γεώργιος Παππάς, G.M. Pendino, Chiara Quarneti, Ronny Cicola, (unknown), S. Ferri, F. Cassani, Francesco B. Bianchi, Marco Lenzi, Luigi Muratori	73
9	HCV and Autoimmunity 2008 ·Current Pharmaceutical Design ·S. Ferri, Luigi Muratori, Marco Lenzi, Alessandro Granito, F.B. Bianchi, Diego Vergani	55
10	Moderatismo e amministrazione nel Granducato di Toscana : la carriera di Luigi Serristori 2007 ·Marco Lenzi	0
11	Role of the HLA Class II 2007 ·Annals of the New York Academy of Sciences ·Vallì De Re, Laura Caggiari, Maria Paola Simula, Salvatore De Vita, Cesare Mazzaro, Marco Lenzi, Massimo Galli, Giuseppe Monti, Clodoveo Ferri, Anna Linda Zignego, Armando Gabrielli, Domenico Sansonno, Franco Dammacco, Massimo Libra, Nicoletta Sacchi, Renato Talamini, Michele Spina, Umberto Tirelli, Renato Cannizzaro, Riccardo Dolcetti	13
12	Hepatic steatosis in chronic hepatitis C: impact on response to anti‐viral treatment with peg‐interferon and ribavirin 2005 ·Alimentary Pharmacology & Therapeutics ·M. Guidi, Paolo Muratori, Alessandro Granito, Luigi Muratori, Γεώργιος Παππάς, Marco Lenzi, Francesco B. Bianchi	9
13	Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome breakdown → 2003 ·Hepatology ·Giulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, (unknown), Marco Lenzi, Rita Manini, Stefania Natale, Ester Vanni, Nicola Villanova, Nazario Melchionda, Mario Rizzetto	2144
14	Key Residues of a Major Cytochrome P4502D6 Epitope Are Located on the Surface of the Molecule 2002 ·The Journal of Immunology ·Yun Ma, Mark Thomas, Manabu Okamoto, Dimitrios P. Bogdanos, Sylvia Nagl, Nanda Kerkar, Agnel R. Lopes, Luigi Muratori, Marco Lenzi, Francesco B. Bianchi, Giorgina Mieli‐Vergani, Diego Vergani	64
15	Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort 1999 ·Gut ·Marco Lenzi, Stefano Bellentani, Gioconda Saccoccio, P. Muratori, Flora Masutti, Luigi Muratori, F. Cassani, F.B. Bianchi, Claudio Tiribelli	140
16	Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile 1997 ·Hepatology ·F. Cassani, Michela Cataleta, Pier Paolo Valentini, P. Muratori, Fabrizio Giostra, R. Francesconi, Luigi Muratori, Marco Lenzi, Giampaolo Bianchi, Daniela Zauli, F.B. Bianchi	193
17	Dermatite infectiva associada ao htlv-1 : relato de caso 1996 ·Anais Brasileiros de Dermatologia ·(unknown), (unknown), Marco Lenzi, (unknown), Abelardo Araújo, (unknown), (unknown)	12
18	Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. 1995 ·Gut ·Luigi Muratori, Marco Lenzi, Yuanfang Ma, Michela Cataleta, Giorgina Mieli‐Vergani, Diego Vergani, Francesco B. Bianchi	69
19	Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. 1995 ·Gut ·Marco Lenzi, (unknown), Luigi Muratori, Michela Cataleta, Giorgio Ballardini, F. Cassani, Francesco B. Bianchi	63
20	Hepatocellular Expression of HLA-A, B, C Molecules Predicts Primary Response to Interferon in Patients with Chronic Hepatitis C 1994 ·American Journal of Clinical Pathology ·Giorgio Ballardini, Paolo Groff, Fabrizio Giostra, Raffaella Francesconi, Daniela Zauli, (unknown), Marco Lenzi, F. Cassani, Francesco Paolo Bianchi	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact